| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.CIR.103.4.576 |
| P698 | PubMed publication ID | 11157725 |
| P50 | author | Katrin Schäfer | Q72735535 |
| P2093 | author name string | Konstantinides S | |
| Loskutoff DJ | |||
| Thinnes T | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | plasminogen | Q107129060 |
| P304 | page(s) | 576-583 | |
| P577 | publication date | 2001-01-01 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Plasminogen activator inhibitor-1 and its cofactor vitronectin stabilize arterial thrombi after vascular injury in mice | |
| P478 | volume | 103 |
| Q51361802 | Adipose Tissue-Derived Plasminogen Activator Inhibitor-1 Function and Regulation. |
| Q35995696 | Ambient particulate matter accelerates coagulation via an IL-6-dependent pathway |
| Q37157980 | Antithrombotic effects of targeting alphaIIbbeta3 signaling in platelets |
| Q36194556 | Autoantibodies to heat shock protein 60 promote thrombus formation in a murine model of arterial thrombosis |
| Q37284133 | Cardiovascular-renal complications and the possible role of plasminogen activator inhibitor: a review |
| Q28222482 | Characterization of a novel bifunctional mutant of staphylokinase with platelet-targeted thrombolysis and antiplatelet aggregation activities |
| Q37734885 | Does plasmin have anticoagulant activity? |
| Q24545469 | EGFL7 is a chemoattractant for endothelial cells and is up-regulated in angiogenesis and arterial injury |
| Q38707419 | Endothelial Repair and Regeneration Following Intimal Injury |
| Q35627011 | Endothelial progenitor cells inhibit platelet function in a P-selectin-dependent manner |
| Q36860966 | Ethyl acetate extract from tissue-cultured mountain ginseng adventitious roots inhibits in vitro platelet aggregation in whole human blood and augments peripheral blood flow in mice |
| Q48744236 | Expression of the leptin receptor in different types of vascular lesions. |
| Q30479254 | Extracellular RNA constitutes a natural procoagulant cofactor in blood coagulation |
| Q39340394 | Ferric Chloride-induced Murine Thrombosis Models |
| Q41769283 | Ferric Chloride-induced Thrombosis Mouse Model on Carotid Artery and Mesentery Vessel. |
| Q30585424 | Ferric chloride-induced murine carotid arterial injury: A model of redox pathology |
| Q42595647 | Homocysteine inhibits neoangiogenesis in mice through blockade of annexin A2-dependent fibrinolysis |
| Q36521250 | Hyperglycemia in acute ischemic stroke: a vascular perspective. |
| Q36415843 | Impaired fibrinolysis and risk for cardiovascular disease in the metabolic syndrome and type 2 diabetes |
| Q24294902 | Inhibition of platelet adhesion and aggregation by a defined region (Gly-486-Lys-502) of high molecular weight kininogen |
| Q28364491 | Leptin-dependent platelet aggregation and arterial thrombosis suggests a mechanism for atherothrombotic disease in obesity |
| Q40224083 | Mannose-binding lectin-associated serine protease-1 is a significant contributor to coagulation in a murine model of occlusive thrombosis |
| Q40756547 | Molecular interactions and functional interference between vitronectin and transforming growth factor-beta |
| Q75243179 | Neointima formation and thrombosis after vascular injury in transgenic mice overexpressing plasminogen activator inhibitor-1 (PAI-1) |
| Q37240183 | Overview of murine thrombosis models |
| Q35626565 | PAI-1 and vasculopathy: the debate continues. |
| Q30477630 | Plasma fibronectin promotes thrombus growth and stability in injured arterioles |
| Q44546029 | Plasma vitronectin levels in patients with coronary atherosclerosis are increased and correlate with extent of disease. |
| Q34021916 | Plasminogen activator-1 overexpression decreases experimental postthrombotic vein wall fibrosis by a non-vitronectin-dependent mechanism. |
| Q34673739 | Platelet adhesion under flow |
| Q28743269 | Platelets retain high levels of active plasminogen activator inhibitor 1 |
| Q93108461 | Preclinical Development of a vWF Aptamer to Limit Thrombosis and Engender Arterial Recanalization of Occluded Vessels |
| Q42952013 | Protein Z-deficiency is associated with enhanced neointima formation and inflammatory response after vascular injury in mice. |
| Q35750010 | Rapidly regulating platelet activity in vivo with an antidote controlled platelet inhibitor |
| Q84586505 | Serum vitronectin levels in patients with Behçet's disease |
| Q35868825 | The antithrombotic potential of selective blockade of talin-dependent integrin alpha IIb beta 3 (platelet GPIIb-IIIa) activation |
| Q89068692 | The endothelial tumor suppressor p53 is essential for venous thrombus formation in aged mice |
| Q91723836 | Thrombocytopenia-associated mutations in Ser/Thr kinase MASTL deregulate actin cytoskeletal dynamics in platelets |
| Q35049481 | Thrombolytic effects of the snake venom disintegrin saxatilin determined by novel assessment methods: a FeCl3-induced thrombosis model in mice |
| Q34979663 | Vitronectin accumulates in the interstitium but minimally impacts fibrogenesis in experimental chronic kidney disease |
| Q73417880 | Vitronectin in human breast carcinomas |
| Q41228470 | α(1,3)-Fucosyltransferases FUT4 and FUT7 control murine susceptibility to thrombosis |
| Q30581666 | β₂-Adrenergic agonists augment air pollution-induced IL-6 release and thrombosis |
Search more.